Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 4 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth | Investing.com UK
Investing.com· 17 hours agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 4 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 14 hours agoIn the first quarter alone, the company began pivotal phase 3 trials with two still-experimental...
Pfizer's LORBRENA shows sustained NSCLC patient benefit over five years By Investing.com
Investing.com· 4 days agoPfizer Inc. (NYSE: NYSE:PFE) has released new data from its Phase 3 CROWN trial, which shows a...
Column: US appellate courts split on threshold for lawsuits challenging diversity programs
Reuters· 2 hours agoThe Atlanta-based 11th U.S. Circuit Court of Appeals, as my colleague Mike Scarcella reported,...
EU regulator backs use of Pfizer's gene therapy for rare bleeding disorder
Reuters via AOL· 5 days agoThe regulator has recommended granting a 'conditional marketing authorization,' which is for the...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 1 day agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 4 days agoQ1 Earnings & Sales Top, EPS Guidance Raised Pfizer’s first-quarter results were strong as it beat...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 6 days agoBut for investors, the details about how those billions will be spent, and how those winning...